Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Dal Pra

Showing results (61-70 of 89) with videos related to

Pageof 9
Sort By:
Current Oncology (Toronto, Ont.)|June 27, 2023
Multi-Institutional Patterns of Use of Tumor-Treating Fields for Patients with Malignant Pleural MesotheliomaTugce Kutuk, Joshua M Walker, Matthew T Ballo, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|June 29, 2017
Salvage radiotherapy for macroscopic local recurrences after radical prostatectomy : A national survey on patterns of practiceAlan Dal Pra, Cedric Panje, Thomas Zilli, et al.
International Journal of Radiation Oncology, Biology, Physics|October 25, 2025
Integration of Habitat Risk Score in Radiation Therapy for Prostate CancerEvangelia I Zacharaki, Adrian L Breto, Ahmad Algohary, et al.
Physics and Imaging in Radiation Oncology|November 20, 2024
Integrated framework for quantitative T2-weighted MRI analysis following prostate cancer radiotherapyEvangelia I Zacharaki, Adrian L Breto, Ahmad Algohary, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 7, 2017
Impact of dose intensified salvage radiation therapy on urinary continence recovery after radical prostatectomy: Results of the randomized trial SAKK 09/10Pirus Ghadjar, Stefanie Hayoz, Jürg Bernhard, et al.
NMR in Biomedicine|November 22, 2023
Uncovering prostate cancer aggressiveness signal in T2-weighted MRI through a three-reference tissues normalization techniqueAhmad Algohary, Evangelia I Zacharaki, Adrian L Breto, et al.
Cancers|November 14, 2023
Clinical-Genomic Risk Group Classification of Suspicious Lesions on Prostate Multiparametric-MRIRadka Stoyanova, Olmo Zavala-Romero, Deukwoo Kwon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2013
TMPRSS2-ERG status is not prognostic following prostate cancer radiotherapy: implications for fusion status and DSB repairAlan Dal Pra, Emilie Lalonde, Jenna Sykes, et al.
European Urology Focus|July 21, 2017
Clinical Perspectives from Randomized Phase 3 Trials on Prostate Cancer: An Analysis of the ClinicalTrials.gov DatabaseAlexandros Tsikkinis, Nikola Cihoric, Gianluca Giannarini, et al.
The Journal of Urology|December 28, 2020
Heterogeneity in Genomic Risk Assessment from Tissue Based Prognostic Signatures Used in the Biopsy Setting and the Impact of Magnetic Resonance Imaging Targeted BiopsySanoj Punnen, Radka Stoyanova, Deukwoo Kwon, et al.
Pageof 9

Showing results (61-70 of 89) with videos related to

Sort By:
Pageof 9
Current Oncology (Toronto, Ont.)|June 27, 2023
Multi-Institutional Patterns of Use of Tumor-Treating Fields for Patients with Malignant Pleural MesotheliomaTugce Kutuk, Joshua M Walker, Matthew T Ballo, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|June 29, 2017
Salvage radiotherapy for macroscopic local recurrences after radical prostatectomy : A national survey on patterns of practiceAlan Dal Pra, Cedric Panje, Thomas Zilli, et al.
International Journal of Radiation Oncology, Biology, Physics|October 25, 2025
Integration of Habitat Risk Score in Radiation Therapy for Prostate CancerEvangelia I Zacharaki, Adrian L Breto, Ahmad Algohary, et al.
Physics and Imaging in Radiation Oncology|November 20, 2024
Integrated framework for quantitative T2-weighted MRI analysis following prostate cancer radiotherapyEvangelia I Zacharaki, Adrian L Breto, Ahmad Algohary, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 7, 2017
Impact of dose intensified salvage radiation therapy on urinary continence recovery after radical prostatectomy: Results of the randomized trial SAKK 09/10Pirus Ghadjar, Stefanie Hayoz, Jürg Bernhard, et al.
NMR in Biomedicine|November 22, 2023
Uncovering prostate cancer aggressiveness signal in T2-weighted MRI through a three-reference tissues normalization techniqueAhmad Algohary, Evangelia I Zacharaki, Adrian L Breto, et al.
Cancers|November 14, 2023
Clinical-Genomic Risk Group Classification of Suspicious Lesions on Prostate Multiparametric-MRIRadka Stoyanova, Olmo Zavala-Romero, Deukwoo Kwon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2013
TMPRSS2-ERG status is not prognostic following prostate cancer radiotherapy: implications for fusion status and DSB repairAlan Dal Pra, Emilie Lalonde, Jenna Sykes, et al.
European Urology Focus|July 21, 2017
Clinical Perspectives from Randomized Phase 3 Trials on Prostate Cancer: An Analysis of the ClinicalTrials.gov DatabaseAlexandros Tsikkinis, Nikola Cihoric, Gianluca Giannarini, et al.
The Journal of Urology|December 28, 2020
Heterogeneity in Genomic Risk Assessment from Tissue Based Prognostic Signatures Used in the Biopsy Setting and the Impact of Magnetic Resonance Imaging Targeted BiopsySanoj Punnen, Radka Stoyanova, Deukwoo Kwon, et al.
Pageof 9